Baby KJ was a pioneer before he was even a year old. Born in 2024 with a rare, life-threatening genetic mutation, Nicole and ...

New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease, a ...

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the stocks that could 10x over the next 10 years. Piper Sandler boosted its ...

The scientists who treated Baby KJ say the FDA's strict standards will make it much harder to create bespoke gene editing for ...

Treatment with the investigational base-editing gene therapy ristoglogene autogetemcel (risto-cel) showed promise in patients with sickle cell disease, according to an interim ana ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a ...

New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease , a genetic blood disorder with ...

A local research group is preparing to launch a first-of-its-kind gene editing study aimed at helping people with severe ...

Doctor Michael Koren, with Encore Research Group of Jacksonville Center for Clinical Research, will be working on the gene ...

Jacksonville may host one of the first U.S. gene‑editing trials aimed at permanently lowering LDL in inherited high ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the ...

Researchers in Mexico are turning their focus towards a revolutionary technique to enhance crop resilience. According to News Arena India, the International Maize and Wheat Improvement Center, also ...